Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Biology, Medicine, & Natural Product Chemistry
Kenneth Kelechi Anachuna
Delta State University, Abraka
Biochemistry, Genetics & Molecular Biology Medicine & Pharmacology Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Streptozotocin-deoxycorticosterone Acetate-induced Haematotoxicity, Hepatorenal Damage and Oxidative Stress in Diabetic-hypertensive rats: Protective Role of Losartan, Metformin and Glibenclamide Combination Therapy Emuesiri Goodies Moke; Benneth Ben-Azu; Emuesiri Kohworho Umukoro; Peace Omewomano Onyilo; Paul Chinwuba; Onos Onoriode Emoyan; Kenneth Kelechi Anachuna; Ighodaro Igbe; Eric Kelly I Omogbai
Biology, Medicine, & Natural Product Chemistry Vol 15, No 1 (2026)
Publisher : Sunan Kalijaga State Islamic University & Society for Indonesian Biodiversity

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.14421/biomedich.2026.151.993-1002

Abstract

Diabetes mellitus and hypertension frequently coexist, exacerbating organ damage. This study investigated the protective effects of combination therapy with losartan (L), metformin (M), and glibenclamide (G) against Streptozotocin-deoxycorticosterone acetate (STZ/DOCA)-induced injuries in a diabetic-hypertensive rat model. Male Wistar rats were divided into five groups: normal control, STZ/DOCA control, and three treatment groups receiving L+M (LM), L+G (LG), or L+M+G (LMG). Hematological, biochemical, oxidative stress, and histopathological analyses were performed after 8 weeks. STZ/DOCA administration induced significant hematotoxicity, hepatorenal dysfunction, and oxidative stress, evidenced by altered blood parameters, elevated liver enzymes (AST, ALT), increased urea, creatinine, and malondialdehyde (MDA), alongside reduced antioxidants (GSH, SOD). Histopathology revealed severe hepatic and renal damage. All treatments provided protection, with the LMG combination showing the most comprehensive amelioration of all measured parameters and the best preservation of liver and kidney architecture. Triple therapy with losartan, metformin, and glibenclamide demonstrated superior synergistic protection against combined diabetic-hypertensive organ damage, highlighting its potential therapeutic promise for this complex comorbidity
Co-Authors Benneth Ben-Azu Emuesiri Goodies Moke Emuesiri Kohworho Umukoro Eric Kelly I Omogbai Ighodaro Igbe Onos Onoriode Emoyan Paul Chinwuba Peace Omewomano Onyilo